Live Breaking News & Updates on Covaxin Adverse Affect

Covaxin
Bharat Biotech reiterated that the Drugs Controller General of India (DCGI) had authorised the restricted use of Covaxin under clinical trial mode .
Individuals who are prioritised under the public health programme of the Health Ministry will be covered under this endeavour. Informing the individuals about the offer to vaccinate them with Covaxin will rest with the respective government programme officials. Those offered Covaxin at pre-specified booths will have the option to receive or reject the administration of the vaccine, says the fact sheet that surfaced on Tuesday.
Company sources told IANS that the fact sheet was issued last week. ....

Andhra Pradesh , Adar Poonawalla , Saket Gokhale Saketgokhale , Central Ethics Committee , National Institute Of Virology , Bharat Biotech International , Indian Council Of Medical Research , Health Ministry , Serum Institute Of India At Pune , Serum Institute Of India , Oxford University , Serum Institute , Drugs Controller General , Saket Gokhale , Representational Image , Bharat Biotech , Indian Council , Medical Research , National Institute , Serious Adverse Events , Bharat Biotech International Limited , Ethics Committee , Covaxin Fact Sheet , Covaxin Adverse Affect , Covaxin Risks , Avoid Covaxin ,